AOL
Showing 1 - 25 of 326
(DIVA) in Medium-vessel-occlusion Strokes: a Retrospective Study
Not yet recruiting
- Acute Ischemic Stroke Due to Medium-vessel-occlusion
- alteplase
- Alteplase + possible complementary IVT with tenecteplase
-
Corbeil-Essonnes, FranceCentre Hospitalier Sud Francilien
Apr 13, 2023
Early Recanalization After Intravenous Thrombolysis With
Recruiting
- Acute Distal Vessel Occlusion Stroke
- Alteplase (0.9mg/kg)
- Tenecteplase (0.25mg/kg)
-
Corbeil-Essonnes, FranceCentre Hospitalier Sud Francilien
Jan 2, 2023
Coronary Artery Disease, Aortic Valve Disease, Mitral Valve Disease Trial (CO/CI/SVR)
Not yet recruiting
- Coronary Artery Disease
- +2 more
- CO/CI/SVR
- (no location specified)
Oct 27, 2023
Hypertension Trial in Carrollton (Determine the presence of Human sequence Ang-(1-12) on no medication, Human sequence
Recruiting
- Hypertension
- Determine the presence of Human sequence Ang-(1-12) on no medication
- Human sequence Ang-(1-12) on Lisinopril 40mg every day
-
Carrollton, TexasPunzi Medical Center
Dec 6, 2022
Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)
Recruiting
- Acute Ischemic Stroke
- Basilar Artery Occlusion
- Best medical management
- Endovascular treatment
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 20, 2023
Refractix DSP and TS Meter-DSP Measurement Comparison
Not yet recruiting
- Healthy
- Serum Total Protein Measurement with TS Meter-DSP and Refractix DSP
-
Lauderhill, FloridaHemarus Plasma
Jan 30, 2023
New Barrett TAL Formula With Argos Measurements: A Multicenter
Recruiting
- Cataract
- Argos
-
Encino, California
- +5 more
Oct 10, 2023
Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive molecular panel test, EORTC QLQ-30)
Not yet recruiting
- Stage III Solid Tumors
- Stage IV Solid Tumors
- Comprehensive molecular panel test
- EORTC QLQ-30
- (no location specified)
Jan 25, 2023
Dry Eye Disease Trial in Venice (Varenicline solution, Placebo nasal spray (OC-01 Vehicle Nasal Spray))
Recruiting
- Dry Eye Disease
- Varenicline solution
- Placebo nasal spray (OC-01 Vehicle Nasal Spray)
-
Venice, FloridaStephenson Eye Associates
Aug 23, 2022
Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive liquid molecular panel test, EORTC QLQ-30)
Not yet recruiting
- Stage III Solid Tumors
- Stage IV Solid Tumors
- Comprehensive liquid molecular panel test
- EORTC QLQ-30
- (no location specified)
Jan 30, 2023
ACL Tear Trial (Scanner)
Not yet recruiting
- ACL Tear
- Scanner
- (no location specified)
Jun 23, 2023
Basilar Artery Occlusion, Endovascular Treatment Trial in China (Contact aspiration Thrombectomy, Stent retriever thrombectomy)
Recruiting
- Basilar Artery Occlusion
- Endovascular Treatment
- Contact aspiration Thrombectomy
- Stent retriever thrombectomy
-
Hefei, Anhui, China
- +5 more
Nov 17, 2022
Daily Disposable Multifocal Contact Lens is Intended for Use for the Correction of Refractive Ametropia (Myopia and Hyperopia)
Recruiting
- Daily Disposable Multifocal Contact Lens is Intended for Use for the Correction of Refractive Ametropia (Myopia and Hyperopia) and Presbyopia
- new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens
-
San Diego, California
- +19 more
Dec 13, 2022
Aortic Valve Stenosis Trial (balloon-expandable valve, self-expanding valve)
Not yet recruiting
- Aortic Valve Stenosis
- balloon-expandable valve
- self-expanding valve
- (no location specified)
Jul 7, 2022
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Rheumatoid Arthritis Trial in Matsumoto (The effectiveness of Xeljanz in rheumatoid arthritis patients)
Recruiting
- Rheumatoid Arthritis
- The effectiveness of Xeljanz in rheumatoid arthritis patients
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
To Examine Whether or Not Primary Causes of OA or RA Might be
Recruiting
- Progression of Rheumatoid Arthritis
- Osteoarthritis of Multiple Joints
- The examinations for bones in joints of OA and RA patients
-
Matsumoto, Nagano, Japan
- +1 more
Sep 20, 2021
Osteoporosis Trial in Komagane (Ibandronic acid, vitamin D)
Recruiting
- Osteoporosis
- Ibandronic acid, vitamin D
-
Komagane, Nagano, JapanShowa Inan General Hospital
Sep 20, 2021
Osteoporosis Trial in Matsumoto ("Zoledronic acid", "Reclast®", "Zoledronic acid", "Reclast®" and "active vitamin D",
Recruiting
- Osteoporosis
- "Zoledronic acid", "Reclast®"
- "Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
Gastrointestinal Erosions and/or Ulcers Trial in Matsumoto (Oral Bonoprazan, Oral Esomeprazol)
Recruiting
- Gastrointestinal Erosions and/or Ulcers
- Oral Bonoprazan
- Oral Esomeprazol
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
Cataract Trial in United States (AcrySof® IQ PanOptix®, Synergy®, Cataract Surgery)
Recruiting
- Cataract
- AcrySof® IQ PanOptix®
- +2 more
-
Panama City, Florida
- +4 more
Jan 10, 2022
Contraception, Women at Risk for Pregnancy Trial in United States (LevoCept)
Not yet recruiting
- Contraception
- Women at Risk for Pregnancy
-
Berkeley, California
- +29 more
Apr 4, 2022
Basilar Artery Occlusion Trial in France (Contact aspiration Thrombectomy, Stent retriever thrombectomy)
Not yet recruiting
- Basilar Artery Occlusion
- Contact aspiration Thrombectomy
- Stent retriever thrombectomy
-
Bordeaux, France
- +11 more
Aug 2, 2022